奥拉西坦(oxiracetam),1974年首先由ISF公司研制成功,1987年在意大利以Neuromet批准上市。自从上市以来,由于其疗效肯定而得到广泛应用,已有注射剂、胶囊剂等剂型。奥拉西坦经美国食品和药品管理局批准,除作为老年痴呆治疗药物外,还可用来治疗多种原因引起的学习、记忆衰退(如低氧、外伤及神经退行性病变和慢性脑功能不全),儿童 Oxiracetam was first developed by ISF in 1974 and approved by Neuromet in Italy in 1987. Since the market has been widely used because of its positive effect, there have been injection, capsule and other dosage forms. Oxiracetam, approved by the U.S. Food and Drug Administration, can be used to treat learning, memory loss (such as hypoxemia, trauma and neurodegeneration, and chronic brain dysfunction ),child